Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shinichiro Kawata
Effects of Switching From a Dipeptidyl Peptidase-4 Inhibitor to Luseogliflozin on Nocturnal Blood Pressure in Patients With Type 2 Diabetes: Protocol for a Multicentre, Prospective, Randomised, Open-Label, Blinded Endpoint Parallel-Group Comparison Study
BMJ Open
Medicine
Related publications
Cost-Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Monotherapy in Elderly Type 2 Diabetes Patients in Thailand
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin as Monotherapy on Glycemic Control in Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes Mellitus
Frontiers in Pharmacology
Pharmacology
Efficacy of High-Dose Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Glycemic Parameters in Patients With Type 2 Diabetes Estimated With Continuous Glucose Monitoring: A Pilot Study
Integrative Obesity and Diabetes
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education (The BCC Study): Study Protocol for a Randomised, Parallel Open-Label, Intervention Study Focusing on HbA1c and Glucose Variability in Patients With Type 2 Diabetes
BMJ Open
Medicine
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
Study Protocol: Efficacy of Oral Alitretinoin Versus Oral Cyclosporine a in Patients With Severe Recurrent Vesicular Hand Eczema (ALICsA): A Randomised Prospective Open-Label Trial With Blinded Outcome Assessment
BMJ Open
Medicine
Luseogliflozin Reduces Epicardial Fat Accumulation in Patients With Type 2 Diabetes: A Pilot Study
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
